Pronacera

PRONACERA is a biotechnology company focused on developing genetic diagnostic tools and treatments for various medical conditions, including reproductive health, fibromyalgia, and rare or underdiagnosed diseases. Our goal is to optimise healthcare systems by improving both the speed and accuracy of diagnosis. Among our multiple R&D projects, reproductive genomics and functional endometrial molecular biology stand out as key areas of innovation. At PRONACERA, we are constantly seeking the best ways to provide advanced genetic evaluation services for patients whose quality of life is impacted by diagnostic gaps. We operate through a B2B model, partnering with clinics and medical professionals who deliver our extensive range of products to patients. This makes us a key support system for both specialists and patients in making informed genomic decisions. Our company’s growth is driven by continuous research and development, empowering scientists while maintaining a personalised and patient-centred approach.